Evidence map›Paper›PMID 40523004›Full record

Observational studyPloS one2025

National Early Warning Score 2 (NEWS2) as a prognostic tool for adult patients in emergency department: A retrospective observational study.

Nor Safiahani Mhd Yunin, Toh Leong Tan

Abstract readObservational Study
In one paragraph

Observational study in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nor Safiahani Mhd YuninDepartment of Emergency Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia.
Toh Leong TanDepartment of Emergency Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia.ORCID 0000-0002-6771-0141

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The National Early Warning Score 2 (NEWS2) has been widely adopted to assess the severity of illness across various healthcare settings. However, its effectiveness as a prognostic tool specifically within the Emergency Department (ED) has not been validated in Malaysia. This retrospective observational study aimed to evaluate the performance of NEWS2 in predicting hospitalizations, critical care unit admissions, and in-hospital mortality among adult patients in a Malaysian ED, specifically at the Hospital Canselor Tuanku Muhriz. The discriminatory ability of NEWS2 was analysed using the area under the receiver operating characteristic curve. A total of 1906 adult patients were included in the study, with results indicating that NEWS2 demonstrated moderate to excellent performance in predicting outcomes. The AUROC values were 0.71 for hospitalization, 0.75 for critical care admission, and 0.86 for in-hospital mortality. Additionally, subgroup analyses for patients with sepsis and those with COVID-19 were also conducted. NEWS2 score however was not as effective in predicting critical outcomes for these two subgroups, limiting its utility as an early warning tool in diverse clinical scenarios. Overall, the results suggest that NEWS2 is a valuable tool for early risk stratification in the general adult population in the ED. Implementing NEWS2 into routine clinical practice could significantly enhance patient outcomes by promoting timely and informed decision-making, ultimately benefiting both patients and healthcare providers.

Indexed as

COVID-19Early Warning ScoreEmergency Service, HospitalAdultAgedFemaleHospitalizationHospital MortalityHumansMalaysiaMaleMiddle AgedPrognosisRetrospective StudiesROC Curve

Identifiers

PMID40523004
PMCPMC12169516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.